HB1099
PassedSDReschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
South Dakota · Session 2026
Status
Passed
As of Mar 10, 2026
Last Action
Signed by the Governor on March 10, 2026 H.J. 547
Official Source
Official Full Bill TextSummary
A South Dakota bill signed into law on March 10, 2026 reschedules FDA-approved crystalline polymorph psilocybin drug products from Schedule I to Schedule IV. Rescheduling FDA-approved psilocybin to Schedule IV creates a legal framework in South Dakota for dispensing and testing that pharmaceutical product, affecting licensed pharmacies, labs, and potentially medical providers.
What
A South Dakota bill signed into law on March 10, 2026 reschedules FDA-approved crystalline polymorph psilocybin drug products from Schedule I to Schedule IV.
Who
labs and retailers
Why
Rescheduling FDA-approved psilocybin to Schedule IV creates a legal framework in South Dakota for dispensing and testing that pharmaceutical product, affecting licensed pharmacies, labs, and potentially medical providers.
Want to advertise here?
Get your business listed on buyweed.us
Want to advertise here?
Get your business listed on buyweed.us
More South Dakota Cannabis Bills
- SB39Revise provisions relating to industrial hemp.Passed
- HB1160Repeal the medical marijuana oversight committee.In Committee
- HB1065Revise the medical purpose affirmative defense in cannabis prosecution.In Committee
- HB1255Require that the Department of Health accept the medical records of a veteran applying for a medical cannabis registry identification card.Introduced
- HB1211Create a digital registry identification card for medical cannabis patients.Introduced
- SB194Limit the potency of cannabis products sold at medical cannabis dispensaries.Introduced
- SB181Cause the repeal of the medical cannabis chapter upon the federal re-scheduling of cannabis.Introduced
- SB143Require that the Department of Health annually report on public health effects of cannabis use.Introduced
- SB95Require that a medical cannabis cardholder provide a card or card number upon request of a law enforcement officer.Introduced
- SB61Ban hemp-derived intoxicants not for medical purposes.Introduced
- HB1053Require that terminal care facilities allow terminally ill patients to use medical cannabis.Introduced
LEGISLATIVE DATA PROVIDED BY LEGISCAN · LICENSED UNDER CC BY 4.0 · UPDATED Aug 17, 2026